TrialJournal of neuro-oncology2019

First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.

Christopher J Funes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.